Concepedia

Saifee Mullamitha

SM

Statistics

Publications

14

Citations

1.3K

H-Index

14

Active since

2004

Affiliations

University of Manchester(Current)

The Christie Hospital

Cancer Research UK

The Christie NHS Foundation Trust

Manchester University NHS Foundation Trust

Saifee Mullamitha is an author at University of Manchester specializing in medicine, oncology, and pharmacology.

Publications per year

2004–2023

14

Publications

14

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 562 citations · Full text

, , +11

Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Associated With Increased Tumor Vascularized Volume

Gordon C. Jayson, Geoff J.M. Parker, Saifee Mullamitha et al. · Journal of Clinical Oncology · 2004 · 163 citations

, , +17

Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors

Saifee Mullamitha, N.C. Ton, Geoff J.M. Parker et al. · Clinical Cancer Research · 2007 · 142 citations

, , +17

Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Gordon C. Jayson, Cong Zhou, Alison Backen et al. · Nature Communications · 2018 · 76 citations · Full text

, , +17

Phase I Evaluation of CDP791, a PEGylated Di-Fab′ Conjugate that Binds Vascular Endothelial Growth Factor Receptor 2

N.C. Ton, Geoff J.M. Parker, Alan Jackson et al. · Clinical Cancer Research · 2007 · 73 citations · Full text

, , +10

1–5 of 14